Glenmark Pharma is first to launch in India, a Triple-drug FDC of Teneligliptin + Dapagliflozin + Metformin for Type 2 Diabetes in Adults with Co-morbidities
Bangalore, India, October 18, 2023: Glenmark Pharmaceuticals Limited (Glenmark Pharma), a research-led, global pharmaceutical company, has launched in India the...